Porphoria Management - Welchol - tablet form bile binder
There have been discussion regarding cholystyramine's use to deal with lipophilic endotoxins released and porphorins (that are difficult for some folks to manage) the virtue of treating this have been debated here in the past.
I recall, one of our long term members HDWhit took Welchol for the same sort of untoward effects experience with CAP treatment. I am thinking of using Welchol. Seems it would be far more pleasant that the reconsituted powder form of Cholystyramine. Also more portable as a tablet to swallow down.
I am currently waiting on the possible availability bile binding tablet. I hope to add more information in response to my request.
WELCHOL (colesevelam hydrochloride) 625 mg tablet is a non-absorbed, polymeric, lipid-lowering and glucose-lowering agent intended for oral administration. Colesevelam hydrochloride is a high-capacity bile acid-binding molecule.
Colesevelam hydrochloride is poly(allylamine hydrochloride) cross-linked with epichlorohydrin and alkylated with 1-bromodecane and (6-bromohexyl)-trimethylammonium bromide. The chemical name (IUPAC) of colesevelam hydrochloride is allylamine polymer with 1-chloro-2,3-epoxypropane, [6-(allylamino)-hexyl]trimethylammonium chloride and N-allyldecylamine, hydrochloride. Colesevelam hydrochloride is hydrophilic and insoluble in water.
WELCHOL Tablets are an off-white, oval, film-coated, solid tablet containing 625 mg colesevelam hydrochloride. In addition, each tablet contains the following inactive ingredients: magnesium stearate, microcrystalline cellulose, silicon dioxide, HPMC (hydroxypropyl methylcellulose), and acetylated monoglyceride. The tablets are imprinted using a water-soluble black ink.